Datta, I.; Zahoor, I.; Ata, N.; Rashid, F.; Cerghet, M.; Rattan, R.; Poisson, L.M.; Giri, S.
Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis. Metabolites 2024, 14, 493.
https://doi.org/10.3390/metabo14090493
AMA Style
Datta I, Zahoor I, Ata N, Rashid F, Cerghet M, Rattan R, Poisson LM, Giri S.
Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis. Metabolites. 2024; 14(9):493.
https://doi.org/10.3390/metabo14090493
Chicago/Turabian Style
Datta, Indrani, Insha Zahoor, Nasar Ata, Faraz Rashid, Mirela Cerghet, Ramandeep Rattan, Laila M. Poisson, and Shailendra Giri.
2024. "Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis" Metabolites 14, no. 9: 493.
https://doi.org/10.3390/metabo14090493
APA Style
Datta, I., Zahoor, I., Ata, N., Rashid, F., Cerghet, M., Rattan, R., Poisson, L. M., & Giri, S.
(2024). Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis. Metabolites, 14(9), 493.
https://doi.org/10.3390/metabo14090493